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DOWNREGULATION OF FABP4 PROMOTES OSTEOCLAST FORMATION AND
FUNCTION BY ACTING PPAR-g SIGNALING
Yuting Wang, Yonghui Dong, Chao Song, Weiwei Lu, Kun Chen, Hui Liu,
Xuejun Zhang, Anmin Chen
Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, China
Background: Fatty acid-binding proteins (FABPs) are critical mediators of meta-
bolism and inflammatory processes both locally and systemically, and has been
proved not only be responsible for the formation of mature adipocytes but also
function as the key modulator in osteoblast formation and osteogenesis. It has
been reported that FABP4 had the capacity to enhance the adipogenesis of BMSCs,
and broke the balance between adipocyte and osteoblast differentiation in bone
marrow system. Researches on the side effects of Methotrexate chemotherapy,
such as osteopenia, osteoporosis and fractures, also show that the gene expression
of FABP4 is up-regulated in the stromal population. However, the relationship be-
tween FABP4 and osteoclast formation remains poorly understood, our research is
aimed to find out what role FABP4 takes in osteoclast formation and bone
resorption.
Subjects and Methods: BMM was collected from 6-week-old C57/BL6 mice, and
induced to the osteoclast in the presence of M-CSF and RANKL for 6 days, BMS
were used as the inhibitor of FABP4, protein expression of RAP, CK, MMP9, NFATC1,
c-fos and PPAR-g were evaluated on day 1, day 3, and day 5 by Western Blot, RT-
PCR gene expression analysis on TRAP, CK, and MMP9 were also performed on day
2. On day 6, the cells were fixed and stained for TRAP assay in both BMS and
BMS+GW9962 groups. And Pit formation assays on BMS group were also performed
on day 6.
Results: In Western Blot, BMS suppresses expression of FABP4. However, the
expression of TRAP, CK, MMP9, NFATC1, c-fos and PPAR-g were increased on day
1, day 3, and day. RT-PCR gene expression analyses showed TRAP, CK, and MMP9
to be up-regulated on day 2. TRAP assays and Pit formation assays also showed
that osteoclast formation and function is promoted under BMS treatment. We
also investigated whether FABP4 is correlated with PPAR-g and have an effect
on osteoclast genesis by TRAP assays and Western Blot. In Western Blot, the pro-
tein expression of PPARg is decreased. The TRAP assays result also shows that
the formation of osteoclast is suppressed with the additional presence of
GW9662 (a PPARg inhibitor).
Discussion and Conclusion: Our research shows that block FABP4 have a positive
impact on osteoclast formation, which is produced by acting PPAR-gsignaling.
These phenomenon highlighting that the overexpression FABP4 can be a new po-
tential target for treating osteopenia related dysfunction.
http://dx.doi.org/10.1016/j.jot.2016.06.169Session: Disease & Treatment e Tumors
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CXCL12/CXCR4 AXIS PROMOTES VASCULOGENIC MIMICRY VIA PI3K/AKT
SIGNALING IN OSTEOSARCOMA
Liang Qin, An-min Chen, Feng-jing Guo, Qing Yang, Hui Liao
Tongji Hospital, Tongji Medical College, Huazhong University of Science and
Technology, China
Background: The term vasculogenic mimicry (VM) refers to the unique capability
of aggressive tumor cells to mimic the pattern of embryonic vasculogenic net-
works. Although VM has been shown to occur in osteosarcoma, a degree of which
correlates with a poor clinical outcome, the precise molecular events underlying
the process of VM in osteosarcoma have not been well defined. In this study, we
explored osteosarcoma as a VM model in order to investigate the role of
CXCL12/CXCR4 axis in VM formation.
Subjects and Methods: The effect of SDF-1 with different concentrations
(10,100mmol/L) and different action times (1 to 6 days) on the growth of osteosar-
coma cell line MG-63 was detected by Cell Counting Kit-8(CCK-8) analysis. The VM
abilities of osteosarcoma cells were detected by a well-established in vitro 3D
model of VM formation. The expression of CXCR4, Akt and p-Akt were detected
by RT-PCR or Western blot.
Results: Osteosarcoma MG63 cells could form patterned matrix VM or tubular VM in
3D cultures in vitro and CXCL12 effectively promoted the formation of VM struc-
tures. Inhibition of CXCR4 function by an antagonist AMD3100 blocked CXCL12-
induced VM formations of MG63 cells. Furthermore, CXCL12 increased phosphory-
lation of Akt. Additionally, blocking PI3K/Akt Pathway using a PI3K inhibitor
LY294002 decreased CXCL12-induced VM formations of MG63 cells.
Discussion and Conclusion: The results of this study indicate that CXCL12/CXCR4
axis plays an important role in osteosarcoma VM formation more through the PI3K/AKT signaling. Our findings also demonstrate a novel cogitation in inhibition of os-
teosarcoma angiogenesis and metastasis.
http://dx.doi.org/10.1016/j.jot.2016.06.170Session: Disease & Treatment e Skeletal Growth & Development
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ALENDRONATE-MODIFIED LIPOSOME FOR BONE TARGETING GENE DELIVERY
REGULATING MESENCHYMAL STEM CELL MIGRATION
Chuping Zheng, Haobo Pan, Xiaoli Zhao
Shenzhen Institutes of Advanced Technology, Chinese Academy of Science, China
Introduction: Aging is usually related to an increase in metabolic skeletal disorders
such as osteoporosis and bone metastases, accompanied with the decrease in
mesenchymal stem cells (MSCs) number.1 For bone regeneration, directing MSCs
toward the bone surface is a key step for further osteogenic differentiation.2 Stro-
mal cell-derived factor-1 (SDF-1) has been reported with the effect in inducing MSC
migration.3 Construction of the bone targeted gene delivery system would be a
promising way to locally express SDF-1 on bone surface for attracting MSC migra-
tion and differentiation. This study aimed to develop bone targeting liposome by
alendronate (Aln) modification for modulating MSC migration.
Subjects and Methods: Aln was conjugated to DSPE-PEG2000-COOH via carbodii-
mide chemistry through the reaction between carboxyl and amino. Aln-liposome
was prepared using the thin-film hydration method with the component of DOTAP,
DOPE, cholesterol, DSPE-PEG2000 and DSPE-PEG2000-Aln. The morphology of lipo-
somes was observed by TEM. The transfection efficiency was examined by trans-
fection of COS-1 cell with GFP reporter gene and luciferase gene. Bone target
ability was examined using fluorescence absorption test. In vitro cytotoxicity of
Aln-liposome was evaluated by CCK-8 assay. Then Aln-liposome was applied to
SDF-1 gene delivery to MC3T3 osteoblast cells for MSC migration. The expressed
SDF-1 mRNA and protein in MC3T3 cells after transfection were examined by RT-
PCR and Western blot.
Results: Bone targeting Aln-liposome was prepared by conjugating liposome with
alendronate. The average diameter of liposome was around 104 nm measured by
a dynamic light scattering detector. TEM image showed the sphere morphology
of Aln-liposome. The critical DNA complex ratio examined by gel retardation was
1:1 (N/P). The transfection efficiency of Aln-liposome was even higher than that
of Lipofectamine 2000 shown by luciferase and GFP reporter gene expression in
COS-1 cell. The cytotoxicity of Aln-liposome investigated by cck-8 assay was lower
than that of Lipofectamine 2000 in COS-1 cells. More than 90% of cell viability
could be observed in the cells when the concentration of liposomes reached
50 mg/mL. Aln-liposome showed the bone targeting ability in vitro. The binded li-
posomes increased from 13.7% to 61.4% after modification with alendronate by
examining the changes in fluorescence of NBD-labeled liposome after mixed with
hydroxyapatite. Aln-liposome was then applied to deliver SDF-1 gene to MC3T3
osteoblast cells, and its expression was confirmed by PCR and western blot. The
expressed SDF-1 showed the effect in attracting MSC migration in transwell
culture.
Discussion and Conclusion: Alendronate modified liposome showed the bone tar-
geting ability and high gene transfection efficiency. By delivery SDF-1 gene, this
system could attract MSC migration. This study provides a novel potential tech-
nique for bone regeneration.
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CHEMICAL-DRIVEN LINEAGE CONVERSION FROM MOUSE FIBROBLASTS TO
CARTILAGE
Yishan Chen
School of Medicine, Zhejiang University, China
Objective: To overcome the cell source limitation and scar tissue accumulation in
cartilage repair, lineage conversion with transcription factors from fibroblasts to
chondrocytes provides a promising approach. However, genetic manipulation rai-
ses safety concerns in clinical application, while small molecule compounds are
more cost-effective and easily-standardized. This study aims to illustrate the
achievement of a gene-free conversion from mouse fibroblasts to cartilage tissue
by chemical cocktails.
Methods and Materials: In this study we showed that mouse embryonic fibroblasts
(MEFs) could be successfully induced into chondrocytes by a two-stage protocol.
Chemical cocktails and hypoxia atmosphere were essential in the first 6 days, to
